Surgery Partners, Inc. (SGRY) Stock
SGRY has an Alpha Score of 15 out of 100 (poor), computed on Aug 23, 2026 from 3 of 4 sub-scores. 4 of the hedge funds AlphaScala tracks reported SGRY in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $4.89M. Company insiders reported 2 open-market buys and 0 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
What is SGRY's Alpha Score?
How it works →Alpha Score of 15 reflects poor overall profile with poor momentum, weak value, poor quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Aug 23, 2026 · 60 days ago; due for a rescore
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own SGRY?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 291K | $4.89M | -27% |
| Renaissance Technologies Jim Simons (founder) | 130K | $2.19M | NEW |
| Marshall Wace | 95K | $1.60M | +644% |
| Blackstone | 15K | $257.8K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Surgery Partners, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 18, 26 | Deluca Teresa | Director | BUY | 10.0K | $144K |
| Aug 18, 26 | Deluca Teresa | Director | BUY | 11.3K | $161K |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →What are SGRY's key statistics?
Key statistics as of Oct 21, 2026
How does SGRY's valuation compare with the Healthcare sector?
| Metric | SGRY | Healthcare median | Companies in median |
|---|---|---|---|
| Net margin | -2.68% | 9.40% | 92 |
| Return on equity | -5.35% | 11.24% | 99 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Oct 22, 2026). P/E excludes loss-making companies.
SGRY price chart
Powered by TradingViewWhat does Surgery Partners, Inc. do?
Surgery Partners Inc. is a healthcare services holding company that owns and operates a national network of surgical facilities and ancillary services across more than 200 locations in 33 states. It specializes in short-stay surgical care, managing ambulatory surgery centers and surgical hospitals that provide non-emergency procedures in specialties such as orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. The company supports these operations through integrated ancillary services, including multi-specialty physician practices, anesthesia services, diagnostic laboratories, urgent care facilities, and optical services like laboratories and group purchasing organizations. Surgery Partners Inc. focuses on delivering high-quality, cost-effective outpatient care, differentiating itself with a comprehensive model that enhances patient and physician support in the ambulatory healthcare sector. Founded in 2004 and headquartered in Brentwood, Tennessee, it plays a key role in the U.S. healthcare delivery system by emphasizing efficient surgical solutions.